Skip to main content
. 2015 Oct 16;4(12):e996475. doi: 10.1080/2162402X.2014.996475

Figure 6.

Figure 6.

miR-181a and candidate target gene expression in LAM primary cells. (A) miR-181a expression was measured at diagnostic and refractory stages in five AML patients. Expression levels of RNU44 were used as endogenous control (Representative graph of n = 3). (B) mRNA level of indicated potential targets of miR-181a were measured by SYBR-GREEN qRT-PCR at diagnostic and refractory stage in five AML patients. Expression level of GAPDH was used as endogenous control.